AstraZeneca United States
Home
Cardiovascular and Metabolic
Gastrointestinal
Infection
Neuroscience
Oncology
Respiratory
Making Medicines More Affordable
About AstraZeneca

Putting Patients at Risk

Patients who take counterfeit medications may be at risk in many ways:

  • Counterfeit drugs are unlikely to be as effective as genuine products.
  • They may also cause allergic reactions or unexpected side effects.
  • They could make medical conditions worse.
  • In the worst cases, these drugs could be hazardous—or even fatal.

When criminals make and distribute counterfeit drugs, they cost all of us. This cost diverts resources that could be used to help develop new drugs. Each year, AstraZeneca spends billions of dollars researching and developing new products. Our commitment to improve the quality of life for those who suffer from targeted diseases must always extend to product security. For this reason, we take an active role in anticounterfeiting efforts.

We can be successful only if we can ensure that we retain the intellectual property rights to our products. This enables us to protect our core business and provide for future investment in the discovery and development of new medicines for a wide range of diseases.

Search